Trial Profile
Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Mar 2013
Price :
$35
*
At a glance
- Drugs Trichuris suis ova (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms TRIMS-A
- 08 Jan 2013 New trial record
- 06 Nov 2012 New source identified and integrated (EudraCT2008-007549-29: European Clinical Trials Database).